يعرض 1 - 10 نتائج من 91 نتيجة بحث عن '"Annick de Vries"', وقت الاستعلام: 1.44s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial

    المؤلفون: Selma Atalay, Sophie E. Berends, Hans M. M. Groenewoud, Ron A. A. Mathot, David M. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. A. Koetsier, Maartje A. Berends, Annick de Vries, Peter C. M. van de Kerkhof, Alfons A. den Broeder, Elke M. G. J. de Jong, Juul M. P. A. van den Reek

    المصدر: Journal of Dermatological Treatment, Vol 33, Iss 5, Pp 2680-2684 (2022)

    مصطلحات موضوعية: psoriasis, adalimumab, etanercept, ustekinumab, dose reduction, dose tapering, Dermatology, RL1-803

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/0954-6634Test; https://doaj.org/toc/1471-1753Test

    الوصول الحر: https://doaj.org/article/536a53e9789542ddb193b8939be0e2ccTest

    View record in DOAJ

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove

    المؤلفون: Teresa Tsakok, Jake Saklatvala, Theo Rispens, Floris C. Loeff, Annick de Vries, Michael H. Allen, Ines A. Barbosa, David Baudry, Tejus Dasandi, Michael Duckworth, Freya Meynell, Alice Russell, Anna Chapman, Sandy McBride, Kevin McKenna, Gayathri Perera, Helen Ramsay, Raakhee Ramesh, Kathleen Sands, Alexa Shipman, the Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group, A. David Burden, Christopher E.M. Griffiths, Nick J. Reynolds, Richard B. Warren, Satveer Mahil, Jonathan Barker, Nick Dand, Catherine Smith, Michael A. Simpson

    المصدر: JCI Insight, Vol 8, Iss 4 (2023)

    مصطلحات موضوعية: Genetics, Therapeutics, Medicine

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2379-3708Test

    الوصول الحر: https://doaj.org/article/b7bce9e049e346049f02cc279904382bTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non–small cell lung cancer after a single 200 mg administration

    المؤلفون: Fenna de Vries, Adrianus A. J. Smit, Gertjan Wolbink, Annick de Vries, Floris C. Loeff, Eric J. F. Franssen

    المصدر: Frontiers in Oncology, Vol 12 (2023)

    مصطلحات موضوعية: pembrolizumab, immunotherapy, immune-related adverse events, programmed cell death protein 1 (PD-1), pharmacodynamic (PD), pharmacokinetic (PK), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.960116/fullTest; https://doaj.org/toc/2234-943XTest

    الوصول الحر: https://doaj.org/article/80f9f5ef5d7443cb95508f45902e8801Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial

    المؤلفون: Maike H. M. Wientjes, Sadaf Atiqi, Gerrit Jan Wolbink, Michael T. Nurmohamed, Maarten Boers, Theo Rispens, Annick de Vries, Ronald F. van Vollenhoven, Bart J. F. van den Bemt, Alfons A. den Broeder

    المصدر: Trials, Vol 22, Iss 1, Pp 1-9 (2021)

    مصطلحات موضوعية: Rheumatoid arthritis, Adalimumab, Anti-TNF, Therapeutic drug monitoring, Drug concentration, Switching, Medicine (General), R5-920

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1745-6215Test

    الوصول الحر: https://doaj.org/article/469fd6c7ea734e45953465a9681f5bdbTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses

    المؤلفون: Jose M. Serra López-Matencio, Yaiza Pérez García, Virginia Meca-Lallana, Raquel Juárez-Sánchez, Angeles Ursa, Lorena Vega-Piris, Dora Pascual-Salcedo, Annick de Vries, Theo Rispens, Cecilia Muñoz-Calleja

    المصدر: Frontiers in Neurology, Vol 12 (2021)

    مصطلحات موضوعية: natalizumab, pharmacokinetics, pharmacodynamics, multiple sclerosis, α4-integrin, dose scheme, Neurology. Diseases of the nervous system, RC346-429

    وصف الملف: electronic resource

    العلاقة: https://www.frontiersin.org/articles/10.3389/fneur.2021.716548/fullTest; https://doaj.org/toc/1664-2295Test

    الوصول الحر: https://doaj.org/article/00d5210b73f64d3e8faaa7e2f3202f45Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial

    المؤلفون: Grégoire Cormier, Benoit Le Goff, Emmanuelle Dernis, Philippe Goupille, Aleth Perdriger, Theo Rispens, David Ternant, Gilles Paintaud, Emilie Ducourau, Marine Samain, Fabienne Le Guilchard, Lucia Andras, Eric Lespessailles, Antoine Martin, Thomas Armingeat, Valérie Devauchelle-Pensec, Elisabeth Gervais, Annick de Vries, Eric Piver, Céline Desvignes, Hervé Watier, Denis Mulleman

    المصدر: RMD Open, Vol 6, Iss 1 (2020)

    مصطلحات موضوعية: Medicine

    وصف الملف: electronic resource

    العلاقة: https://rmdopen.bmj.com/content/6/1/e001047.fullTest; https://doaj.org/toc/2056-5933Test

    الوصول الحر: https://doaj.org/article/34baabbabbb84c789d1f58a0aed02800Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Mast cells play no role in the pathogenesis of postoperative ileus induced by intestinal manipulation.

    المؤلفون: Pedro J Gomez-Pinilla, Giovanna Farro, Martina Di Giovangiulio, Nathalie Stakenborg, Andrea Némethova, Annick de Vries, Adrian Liston, Thorsten B Feyerabend, Hans-Reimer Rodewald, Guy E Boeckxstaens, Gianluca Matteoli

    المصدر: PLoS ONE, Vol 9, Iss 1, p e85304 (2014)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    العلاقة: http://europepmc.org/articles/PMC3887017?pdf=renderTest; https://doaj.org/toc/1932-6203Test

    الوصول الحر: https://doaj.org/article/66fd3e2ec9e946bebf635b90d4b29638Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Correction: Mast Cells Play No Role in the Pathogenesis of Postoperative Ileus Induced by Intestinal Manipulation.

    المؤلفون: Pedro J. Gomez-Pinilla, Giovanna Farro, Martina Di Giovangiulio, Nathalie Stakenborg, Andrea Némethova, Annick de Vries, Adrian Liston, Thorsten B. Feyerabend, Hans-Reimer Rodewald, Guy E. Boeckxstaens, Gianluca Matteoli

    المصدر: PLoS ONE, Vol 9, Iss 1 (2014)

    مصطلحات موضوعية: Medicine, Science

    وصف الملف: electronic resource

    العلاقة: http://europepmc.org/articles/PMC3908733Test; https://doaj.org/toc/1932-6203Test

    الوصول الحر: https://doaj.org/article/f9dd2506dd244e52ae38b6ccb55792d6Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Additional file 1 of Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial

    المؤلفون: Maike H. M. Wientjes (10996986), Sadaf Atiqi (10996989), Gerrit Jan Wolbink (10996992), Michael T. Nurmohamed (9199598), Maarten Boers (15835), Theo Rispens (216183), Annick de Vries (508025), Ronald F. van Vollenhoven (2851577), Bart J. F. van den Bemt (4500796), Alfons A. den Broeder (9176663)

    مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Ecology, Immunology, Cancer, Mental Health, Computational Biology, Rheumatoid arthritis, Adalimumab, Anti-TNF, Therapeutic drug monitoring, Drug concentration, Switching, Test-treatment trial, Design

    العلاقة: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Using_adalimumab_serum_concentration_to_choose_a_subsequent_biological_DMARD_in_rheumatoid_arthritis_patients_failing_adalimumab_treatment_ADDORA-switch_study_protocol_for_a_fully_blinded_randomised_superiority_test-tre/14812440Test

    الإتاحة: https://doi.org/10.6084/m9.figshare.14812440.v1Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases

    المؤلفون: Charlotte LM Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick DW Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John D Isaacs

    المساهمون: Rheumatology, AII - Inflammatory diseases, APH - Societal Participation & Health, Interne Geneeskunde, MUMC+: MA Reumatologie (9), RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation

    المصدر: Annals of the Rheumatic Diseases, 82(1), 65-73. BMJ Publishing Group
    Annals of the rheumatic diseases, 82(1), 65-73. BMJ Publishing Group
    Krieckaert, C L M, van Tubergen, A, Gehin, J E, Hernández-Breijo, B, le Mélédo, G, Balsa, A, Böhm, P, Cucnik, S, Elkayam, O, Goll, G L, Hooijberg, F, Jani, M, Kiely, P D W, McCarthy, N, Mulleman, D, Navarro-Compán, V, Payne, K, Perry, M E, Plasencia-Rodriguez, C, Stones, S R, Syversen, S W, de Vries, A, Ward, K M, Wolbink, G & Isaacs, J D 2022, ' EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases ', Annals of the Rheumatic Diseases, vol. 82, no. 1, pp. 65-73 . https://doi.org/10.1136/annrheumdis-2022-222155Test

    مصطلحات موضوعية: Ankylosing, ARTHRITIS PATIENTS, Immunology, Psoriatic, Antibodies, General Biochemistry, Genetics and Molecular Biology, Arthritis, Rheumatoid, Rheumatology, Rheumatic Diseases, Rheumatoid, Humans, Immunology and Allergy, Spondylitis, Ankylosing, Pharmacokinetics, Musculoskeletal Diseases, Biological Products, LONG-TERM TREATMENT, Arthritis, Arthritis, Psoriatic, CLINICAL-RESPONSE, ANKYLOSING-SPONDYLITIS, SERUM-LEVELS, OPEN-LABEL, INFLIXIMAB TROUGH LEVELS, Europe, Biological Therapy, ANTI-ADALIMUMAB ANTIBODIES, OF-CARE, PSORIATIC-ARTHRITIS, Drug Monitoring, Spondylitis

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d0434b593d41d54250d4b1af8fec9eTest
    https://doi.org/10.1136/annrheumdis-2022-222155Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث